tldrdailynews.com logo

Vertex bets $10B on Crinetics to reshape endocrinology portfolio

1 min read
Source: Endpoints News
Vertex bets $10B on Crinetics to reshape endocrinology portfolio
Photo: Endpoints News
TL;DR

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for $10 billion, marking the largest deal in Vertex’s history and expanding its commercial endocrinology portfolio with Crinetics’ programs in obesity, diabetes and related endocrine diseases.

Topics:businessdeals#biotech-acquisition#crinetics-pharmaceuticals#deals#endocrinology#pharmaceutical-merger#vertex-pharmaceuticals
Share this article
  1. Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics  Endpoints News
  2. Vertex to Buy Crinetics for $10 Billion in Biggest Deal Yet  Bloomberg.com
  3. Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion  WSJ
  4. CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition  Yahoo Finance
  5. Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms  STAT

Want the full story? Read the original reporting

Read on Endpoints News